Loading...
Market
In how many countries will Nyxoah's Genio device be launched by end of 2025?
2
Resolution / Starting Odds
1 to 5 countries • 25%
6 to 10 countries • 25%
11 to 15 countries • 25%
More than 15 countries • 25%
Press releases from Nyxoah or international market reports
Story
Nyxoah Launches App-Controlled Genio Device in UK for Sleep Apnoea Relief, Fitting First Patients
Dec 13, 2024, 09:57 AM
Nyxoah has announced the commercial launch of its innovative therapy, Genio, in the United Kingdom. This new app-controlled nerve stimulator aims to provide relief for millions suffering from sleep apnoea. The device works by stimulating the nerves in the tongue, helping patients breathe more easily during the night. The first patients in the UK have already been fitted with this microchip, marking a significant advancement in the treatment options available for sleep apnoea. This development is expected to bring relief not only to patients but also to their partners, who often endure the effects of snoring associated with the condition.
View original story
Similar markets
Less than 5 • 33%
5 to 10 • 33%
More than 10 • 33%
1-3 countries • 25%
4-6 countries • 25%
7-9 countries • 25%
10 or more countries • 25%
1-2 countries • 25%
3-5 countries • 25%
6-10 countries • 25%
More than 10 countries • 25%
Less than 10 • 25%
10 to 20 • 25%
21 to 30 • 25%
More than 30 • 25%
Less than 5 countries • 25%
5 to 10 countries • 25%
11 to 20 countries • 25%
More than 20 countries • 25%
Less than 10 • 25%
10 to 20 • 25%
20 to 30 • 25%
More than 30 • 25%
0-5 countries • 25%
6-10 countries • 25%
11-20 countries • 25%
More than 20 countries • 25%
0-5 • 25%
6-10 • 25%
11-20 • 25%
21+ • 25%
No international approvals • 25%
1 to 2 international approvals • 25%
3 to 4 international approvals • 25%
5 or more international approvals • 25%
Less than 10 • 25%
10 to 20 • 25%
20 to 30 • 25%
More than 30 • 25%
Less than 10 • 25%
10 to 20 • 25%
21 to 30 • 25%
More than 30 • 25%
Less than 5 • 25%
5 to 10 • 25%
11 to 15 • 25%
More than 15 • 25%